251 related articles for article (PubMed ID: 23731204)
21. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
[TBL] [Abstract][Full Text] [Related]
22. Echocardiographic predictors of first onset of atrial fibrillation in dogs with myxomatous mitral valve disease.
Baron Toaldo M; Mazzoldi C; Romito G; Poser H; Contiero B; Cipone M; Guglielmini C
J Vet Intern Med; 2020 Sep; 34(5):1787-1793. PubMed ID: 32767718
[TBL] [Abstract][Full Text] [Related]
23. Two-dimensional, long-axis echocardiographic ratios for assessment of left atrial and ventricular size in dogs.
Strohm LE; Visser LC; Chapel EH; Drost WT; Bonagura JD
J Vet Cardiol; 2018 Oct; 20(5):330-342. PubMed ID: 30143416
[TBL] [Abstract][Full Text] [Related]
24. Comparisons of 3-, 2-dimensional, and M-mode echocardiographical methods for estimation of left chamber volumes in dogs with and without acquired heart disease.
Tidholm A; Westling AB; Höglund K; Ljungvall I; Häggström J
J Vet Intern Med; 2010; 24(6):1414-20. PubMed ID: 20840300
[TBL] [Abstract][Full Text] [Related]
25. Utility of focused cardiac ultrasonography training in veterinary students to differentiate stages of subclinical myxomatous mitral valve disease in dogs.
Huh T; Achilles EJ; Massey LK; Loughran KA; Larouche-Lebel É; Convey V; McKaba VF; Crooks A; Kraus MS; Gelzer AR; Oyama MA
J Vet Intern Med; 2024; 38(3):1325-1333. PubMed ID: 38532734
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular twist and circumferential strain in dogs with myxomatous mitral valve disease.
Zois NE; Olsen NT; Moesgaard SG; Rasmussen CE; Falk T; Häggström J; Pedersen HD; Møller JE; Olsen LH
J Vet Intern Med; 2013; 27(4):875-83. PubMed ID: 23731222
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of vertebral left atrial size as determined from thoracic radiographs for assessment of left atrial size in dogs with myxomatous mitral valve disease.
Malcolm EL; Visser LC; Phillips KL; Johnson LR
J Am Vet Med Assoc; 2018 Oct; 253(8):1038-1045. PubMed ID: 30272515
[TBL] [Abstract][Full Text] [Related]
28. Discrepancies in identification of left atrial enlargement using left atrial volume versus left atrial-to-aortic root ratio in dogs.
Wesselowski S; Borgarelli M; Bello NM; Abbott J
J Vet Intern Med; 2014; 28(5):1527-33. PubMed ID: 25056960
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease.
Baron Toaldo M; Romito G; Guglielmini C; Diana A; Pelle NG; Contiero B; Cipone M
J Vet Intern Med; 2018 May; 32(3):914-921. PubMed ID: 29572938
[TBL] [Abstract][Full Text] [Related]
30. Effects of age and gender on left atrial ejection force and volume from real-time three-dimensional echocardiography.
Zhong L; Tan LK; Finn CJ; Ghista D; Liew R; Ding ZP
Ann Acad Med Singap; 2012 Apr; 41(4):161-9. PubMed ID: 22635280
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Right Ventricular Tei Index in Dogs with Myxomatous Mitral Valvular Heart Disease.
Nakamura K; Morita T; Osuga T; Morishita K; Sasaki N; Ohta H; Takiguchi M
J Vet Intern Med; 2016; 30(1):69-75. PubMed ID: 26789419
[TBL] [Abstract][Full Text] [Related]
32. Left atrial volumes, function and work before and after mitral valve repair in chronic mitral regurgitation.
Dardas PS; Pitsis AA; Tsikaderis DD; Mezilis NE; Geleris PN; Boudoulas HK
J Heart Valve Dis; 2004 Jan; 13(1):27-32. PubMed ID: 14765836
[TBL] [Abstract][Full Text] [Related]
33. Plasma atrial natriuretic peptide is an early diagnosis and disease severity marker of myxomatous mitral valve disease in dogs.
Ebisawa T; Ohta Y; Funayama M; Yamano S; Mizuno M; Mizuno T; Kasuya A; Sawada T; Lee J; Mizukoshi T; Uechi M
Res Vet Sci; 2013 Jun; 94(3):717-21. PubMed ID: 23312500
[TBL] [Abstract][Full Text] [Related]
34. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Ablad B; Bussadori CM; Glaus T; Kovacević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir AV; O'Sullivan ML; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016
[TBL] [Abstract][Full Text] [Related]
35. Bronchomalacia in dogs with myxomatous mitral valve degeneration.
Singh MK; Johnson LR; Kittleson MD; Pollard RE
J Vet Intern Med; 2012; 26(2):312-9. PubMed ID: 22332787
[TBL] [Abstract][Full Text] [Related]
36. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
[TBL] [Abstract][Full Text] [Related]
37. Left atrial compensatory function in subjects with early stage primary hypertension assessed by using left atrial volumetric emptying fraction acquired by transthoracic echocardiography.
Wakatsuki Y; Funabashi N; Mikami Y; Shiina Y; Kawakubo M; Takahashi M; Yajima R; Uehara M; Takaoka H; Komuro I
Int J Cardiol; 2009 Aug; 136(3):363-7. PubMed ID: 18678421
[TBL] [Abstract][Full Text] [Related]
38. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
Reimann MJ; Møller JE; Häggström J; Martinussen T; Zatrazemi SSC; Svanholm L; Nielsen LBM; Pedersen HD; Olsen LH
J Vet Intern Med; 2017 Jul; 31(4):1008-1016. PubMed ID: 28573754
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of left atrial function in dogs with chronic mitral valvular heart disease.
Nakamura K; Osuga T; Morishita K; Suzuki S; Morita T; Yokoyama N; Ohta H; Yamasaki M; Takiguchi M
J Vet Intern Med; 2014; 28(6):1746-52. PubMed ID: 25327889
[TBL] [Abstract][Full Text] [Related]
40. Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease.
Sarcinella F; Neves J; Maddox TW; Hodgkiss-Geere HM; Bode EF; Dukes-McEwan J
Open Vet J; 2020 Jan; 9(4):375-383. PubMed ID: 32042661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
